Symbiosis appoints Joanne Anderson as Chief Commercial Officer

Lucy Batizovsky | March 6, 2026 | Appointment | |  Symbiosis Pharmaceutical Services 

Symbiosis Pharmaceutical Services (Symbiosis), a global contract development and manufacturing organisation (CDMO) specialising in the GMP sterile fill-finish manufacturing of injectable drug products, has appointed Joanne Anderson as Chief Commercial Officer (CCO). 
 
Joanne brings over 25 years of international experience in the pharmaceutical industry to the role. She most recently served as Global Key Account Director at Recipharm and previously with other global CDMOs. The appointment marks Joanne’s return to Symbiosis after six years away.
 
Joanne said: “Having previously been part of the Symbiosis team, it is incredibly rewarding to see the journey the company has been on. I am rejoining at an exciting time for Symbiosis and I am keen to lead the commercial team into new markets and explore new opportunities.”
 
The appointment comes at a time of sustained momentum for the Stirling-based CDMO, with significant investment in its manufacturing capacity and the recent successful qualification of its new commercial production facility,
 
Colin MacKay, Chief Executive Officer of Symbiosis, said: “Joanne’s intrinsic understanding of our clients needs, coupled with her extensive global industry network, make her the ideal leader to spearhead our commercial growth.”
 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content